Key result
Trib3 deficiency cuts advanced atherosclerotic plaques ~56% and improves plaque stability in mice.
Why the study?
The role of Tribbles 3 in atherosclerotic plaque development and stability was unclear, despite its association with cardiovascular risk.
Does Trib3 deficiency improve atherosclerotic plaque stability in a mouse model of atherosclerosis?
Does Trib3 deficiency improve atherosclerotic plaque stability in a mouse model of atherosclerosis?
p-value: p=<0.05
Loss of TRIB3 increases fibrous cap thickness and improves plaque stability via altered metalloproteinase expression in macrophages, suggesting it as a potential therapeutic target for unstable plaques.
Tribbles 3 (TRIB3) modulates lipid and glucose metabolism, macrophage lipid uptake, with a gain-of-function variant associated with increased cardiovascular risk. Here we set out to examine the role of this pseudokinase in atherosclerotic plaque development. Human endarterectomy atherosclerotic tissue specimens analysed by immunofluorescence showed upregulated TRIB3 in unstable plaques and an enrichment in unstable regions of stable plaques. Atherosclerosis was induced in full body Trib3 KO and Trib3 WT littermate mice by injecting mPCSK9 expressing adeno-associated virus and western diet feeding for 12 weeks. Trib3 KO mice showed expanded visceral adipose depot while circulatory lipid levels remained unaltered compared to wildtype mice. Trib3 KO mice aortae showed a reduced plaque development and improved plaque stability, with increased fibrous cap thickness and collagen content, which was accompanied by increased macrophage content. Analysis of both mouse and human macrophages with reduced TRIB3 expression showed elongated morphology, increased actin expression and altered regulation of genes involved in extracellular matrix remodelling. In summary, TRIB3 controls plaque development and may be atherogenic in vivo . Loss of TRIB3 increases fibrous cap thickness via altered metalloproteinase expression in macrophages, thus inhibiting collagen and elastic fibre degradation, suggesting a role for TRIB3 in the formation of unstable plaques.
No takes yet. Share an insight, caveat, or question.
Martinez-Campesino et al. (2022) studied Atherosclerosis. Tribbles 3 (TRIB3) deficiency vs. Wild-type (Trib3WT) or normal TRIB3 expression was evaluated on Atherosclerotic plaque stability and progression (fibrous cap thickness, collagen content, and plaque grading) (p=<0.05). Trib3 deficiency in mice resulted in less advanced atherosclerotic disease, with fewer advanced plaques (33% vs 75% in wild-type) and increased fibrous cap thickness and collagen content.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: